Page last updated: 2024-08-24

ibutilide and amiodarone

ibutilide has been researched along with amiodarone in 40 studies

Research

Studies (40)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (7.50)18.2507
2000's27 (67.50)29.6817
2010's8 (20.00)24.3611
2020's2 (5.00)2.80

Authors

AuthorsStudies
Keserü, GM1
Nagashima, R; Nishikawa, T; Tobita, M1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Jia, L; Sun, H1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Sen, S; Sinha, N1
Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
DiMarco, JP; Jung, F1
Bharucha, D; Kowey, PR; Marinchak, RA; Rials, SJ1
Chang, MS; Chen, SA; Chen, YJ; Feng, AN; Tai, CT; Yu, WC1
Sager, PT1
Trohman, RG1
Chatterjee, K; Cheng, J; Glatter, K; Kayser, S; Modin, G; Scheinman, MM; Yang, Y1
Camm, AJ1
Bianconi, L; Castro, A; Santini, M1
Heidland, UE; Heintzen, MP; Hennersdorf, MG; Perings, C; Perings, SM; Strauer, BE; Zühlke, C1
Chugh, A; Greenstein, R; Hassan, S; Knight, BP; Lai, SW; Morady, F; Oral, H; Ozaydin, M; Pelosi, F; Scharf, C; Strickberger, SA; Tada, H1
Calò, L; Pignalberi, C; Ricci, R; Santini, M1
Kao, W; Kowey, PR; Winkel, E; Yan, GX1
Bernard, EO; Candinas, R; Germann, R; Scharf, C; Schmid, ER; Schmidlin, D1
DeBisschop, M; Lower, DL; Martin, LG; Yamreudeewong, W1
Khan, MH1
Li, WZ1
Bleich, M; Brendel, J; Busch, AE; Knobloch, K; Rosenstein, B; Wirth, KJ1
Brendorp, B; Elming, H; Køber, L; Pedersen, OD; Pehrson, S; Torp-Petersen, C1
Dilaveris, P; Gialafos, E; Giannopoulos, G; Stefanadis, C; Synetos, A1
Fragakis, N; Katsaris, G; Kozirakis, M; Maligkos, G; Papadopoulos, N; Papanastasiou, S; Tsaritsaniotis, E1
Scharf, C1
Chaveles, JI; Dagadaki, OK; Kafkas, NV; Kelesidis, KM; Mertzanos, GA; Papageorgiou, KI; Patsilinakos, SP1
Bonios, M; Exarchos, P; Kogias, J; Melexopoulou, C; Sideris, S; Tsatiris, K1
Kluger, J; Shah, SA; White, CM1
Globits, S; Hirschl, MM; Wollmann, C1
Naccarelli, GV; Samii, SM1
Hirayama, A; Kofune, M; Kogawa, R; Mano, H; Nakai, T; Ohkubo, K; Okumura, Y; Sasaki, N; Sonoda, K; Watanabe, I1
Hirayama, A; Kogawa, R; Nakai, T; Ohkubo, K; Okumura, Y; Sasaki, N; Sonoda, K; Takahashi, K; Watanabe, I1
Alhumayyd, MS; Almotrefi, AA; Bukhari, IA1
Chen, K; Han, Y; Huang, S; Jin, Q; Lin, C; Luo, Q; Shen, W; Wei, Y; Wu, L; Zhang, N1
Cacioppo, F; Domanovits, H; Gupta, S; Herkner, H; Laggner, AN; Lutnik, M; Niederdoeckl, J; Oppenauer, J; Roth, D; Schnaubelt, S; Schuetz, N; Schwameis, M; Simon, A; Spiel, AO1

Reviews

14 review(s) available for ibutilide and amiodarone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Antiarrhythmic drug therapy in the treatment of atrial fibrillation.
    Cardiology clinics, 1996, Volume: 14, Issue:4

    Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Electrophysiology; Flecainide; Humans; Ion Channels; Quinidine; Sotalol; Sulfonamides

1996
Pharmacologic and pharmacokinetic profile of class III antiarrhythmic drugs.
    The American journal of cardiology, 1997, Oct-23, Volume: 80, Issue:8A

    Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Humans; Phenethylamines; Sotalol; Sulfonamides

1997
New advances in class III antiarrhythmic drug therapy.
    Current opinion in cardiology, 2000, Volume: 15, Issue:1

    Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrophysiology; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides

2000
Supraventricular tachycardia: implications for the intensivist.
    Critical care medicine, 2000, Volume: 28, Issue:10 Suppl

    Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Electrophysiologic Techniques, Cardiac; Humans; Sulfonamides; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Supraventricular; Verapamil; Wolff-Parkinson-White Syndrome

2000
Clinical differences between the newer antiarrhythmic agents.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2000, Volume: 1 Suppl C

    Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Dronedarone; Heart Conduction System; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sulfonamides

2000
New antiarrhythmic drugs for the treatment of atrial fibrillation.
    Pacing and clinical electrophysiology : PACE, 2002, Volume: 25, Issue:2

    Topics: Aminobenzoates; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides

2002
Hybrid therapy of atrial fibrillation.
    Italian heart journal : official journal of the Italian Federation of Cardiology, 2002, Volume: 3, Issue:10

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Catheter Ablation; Combined Modality Therapy; Electric Countershock; Humans; Sulfonamides

2002
Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches.
    The American journal of cardiology, 2003, Mar-20, Volume: 91, Issue:6A

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Catheter Ablation; Flecainide; Heart Rate; Humans; Phenethylamines; Practice Guidelines as Topic; Propafenone; Quinidine; Stroke; Sulfonamides; Ventricular Dysfunction, Left

2003
Potentially significant drug interactions of class III antiarrhythmic drugs.
    Drug safety, 2003, Volume: 26, Issue:6

    Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Drug Interactions; Humans; Phenethylamines; Sotalol; Sulfonamides

2003
Oral class III antiarrhythmics: what is new?
    Current opinion in cardiology, 2004, Volume: 19, Issue:1

    Topics: Amiodarone; Anti-Arrhythmia Agents; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides; Tachycardia, Supraventricular; Tachycardia, Ventricular; Treatment Outcome

2004
A benefit-risk assessment of class III antiarrhythmic agents.
    Expert opinion on drug safety, 2004, Volume: 3, Issue:6

    Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Combined Modality Therapy; Defibrillators, Implantable; Dronedarone; Heart Conduction System; Humans; Hydantoins; Imidazolidines; Ion Transport; Life Tables; Membrane Potentials; Meta-Analysis as Topic; Phenethylamines; Piperazines; Risk Assessment; Sotalol; Sulfonamides; Survival Analysis; Torsades de Pointes; Treatment Outcome

2004
[Atrial flutter and fibrillation].
    Praxis, 2005, Nov-09, Volume: 94, Issue:45

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Catheter Ablation; Clinical Trials as Topic; Disopyramide; Electric Countershock; Electrocardiography; Emergencies; Flecainide; Heart Rate; Humans; Middle Aged; Pacemaker, Artificial; Propafenone; Quinidine; Recurrence; Sotalol; Sulfonamides; Treatment Outcome; Vasodilator Agents

2005
Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
    Pharmacotherapy, 2007, Volume: 27, Issue:9

    Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Electrophysiologic Techniques, Cardiac; Heart Conduction System; Humans; Sotalol; Sulfonamides; Torsades de Pointes

2007

Trials

3 trial(s) available for ibutilide and amiodarone

ArticleYear
Comparison of amiodarone versus ibutilide for the prevention of immediate recurrences of atrial fibrillation during pulmonary vein isolation.
    The American journal of cardiology, 2002, Sep-01, Volume: 90, Issue:5

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Cross-Over Studies; Electrophysiologic Techniques, Cardiac; Female; Humans; Male; Middle Aged; Prevalence; Prospective Studies; Pulmonary Veins; Recurrence; Sulfonamides; Time Factors; Treatment Outcome

2002
Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study.
    Critical care medicine, 2003, Volume: 31, Issue:4

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Middle Aged; Prospective Studies; Sulfonamides

2003
Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.
    International journal of cardiology, 2007, Jun-12, Volume: 118, Issue:3

    Topics: Acute Disease; Aged; Aged, 80 and over; Amiodarone; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Probability; Prospective Studies; Recurrence; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Sulfonamides; Treatment Outcome

2007

Other Studies

23 other study(ies) available for ibutilide and amiodarone

ArticleYear
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
    Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16

    Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship

2003
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
    Bioorganic & medicinal chemistry letters, 2005, Jun-02, Volume: 15, Issue:11

    Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated

2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Support vector machines classification of hERG liabilities based on atom types.
    Bioorganic & medicinal chemistry, 2008, Jun-01, Volume: 16, Issue:11

    Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:2

    Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship

2011
MICE models: superior to the HERG model in predicting Torsade de Pointes.
    Scientific reports, 2013, Volume: 3

    Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes

2013
Electropharmacologic effects of class I and class III antiarrhythmia drugs on typical atrial flutter: insights into the mechanism of termination.
    Circulation, 1998, May-19, Volume: 97, Issue:19

    Topics: Adult; Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Flutter; Atrial Function; Cardiac Catheterization; Electrophysiology; Female; Heart Conduction System; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Sulfonamides

1998
Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy.
    Circulation, 2001, Jan-16, Volume: 103, Issue:2

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Stroke Volume; Sulfonamides; Torsades de Pointes

2001
Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
    Intensive care medicine, 2002, Volume: 28, Issue:7

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Critical Care; Electric Countershock; Electrocardiography; Germany; Humans; Intensive Care Units; Middle Aged; Sulfonamides; Treatment Outcome

2002
[Progress in the clinical use of anti-arrhythmic drugs (I)].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2003, Volume: 41, Issue:10

    Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Clinical Trials as Topic; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sulfonamides

2003
Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs.
    Medical science monitor : international medical journal of experimental and clinical research, 2004, Volume: 10, Issue:7

    Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Function; Atropine; Biphenyl Compounds; Chromans; Flecainide; Heart Atria; Hydantoins; Imidazoles; Imidazolidines; Male; Phenethylamines; Piperazines; Potassium Channel Blockers; Potassium Channels; Propafenone; Propanolamines; Sotalol; Sulfonamides; Swine; Ventricular Function

2004
Conversion of recent-onset atrial fibrillation or flutter with amiodarone after ibutilide has failed: a rapid, efficient, and safe algorithm.
    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2005, Volume: 10, Issue:3

    Topics: Aged; Algorithms; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chi-Square Distribution; Electrocardiography; Female; Humans; Male; Pilot Projects; Sulfonamides; Treatment Outcome

2005
Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
    Pacing and clinical electrophysiology : PACE, 2005, Volume: 28, Issue:9

    Topics: Adult; Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chi-Square Distribution; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Prospective Studies; Sulfonamides; Treatment Outcome

2005
The role of amiodarone in recent-onset atrial fibrillation after ibutilide has failed to restore sinus rhythm.
    Cardiology, 2007, Volume: 107, Issue:4

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Male; Sulfonamides; Treatment Outcome

2007
A 2-year survey of treatment of acute atrial fibrillation in an ED.
    The American journal of emergency medicine, 2011, Volume: 29, Issue:5

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Diltiazem; Emergency Service, Hospital; Female; Flecainide; Humans; Male; Middle Aged; Sulfonamides; Time Factors; Treatment Outcome

2011
Atrial fibrillation: AVRO--were the results a surprise?
    Nature reviews. Cardiology, 2011, Volume: 8, Issue:4

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Statistics as Topic; Sulfonamides

2011
Rate-dependent electrophysiologic effects of the class III antiarrhythmic drugs nifekalant, amiodarone, and ibutilide on the atrium in patients with persistent atrial fibrillation.
    International heart journal, 2013, Volume: 54, Issue:5

    Topics: Action Potentials; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Female; Heart Atria; Heart Conduction System; Humans; Male; Middle Aged; Pyrimidinones; Sulfonamides

2013
Effects of intravenous amiodarone and ibutilide on action potential duration and atrial conduction kinetics in patients with persistent atrial fibrillation.
    International heart journal, 2014, Volume: 55, Issue:3

    Topics: Action Potentials; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Atria; Heart Conduction System; Humans; Injections, Intravenous; Male; Middle Aged; Sulfonamides; Treatment Outcome

2014
Investigation of the antifibrillatory drug interactions between Amiodarone and Ibutilide in isolated, perfused Rabbit hearts.
    Fundamental & clinical pharmacology, 2015, Volume: 29, Issue:6

    Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Interactions; Heart; Lidocaine; Perfusion; Propranolol; Rabbits; Reproducibility of Results; Sulfonamides; Ventricular Fibrillation

2015
Ibutilide Reduces Ventricular Defibrillation Threshold and Organizes Ventricular Fibrillation Activation in Canine Heart Failure Model.
    Cardiovascular drugs and therapy, 2020, Volume: 34, Issue:3

    Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Arterial Pressure; Disease Models, Animal; Dogs; Heart Failure; Heart Rate; Refractory Period, Electrophysiological; Sulfonamides; Time Factors; Ventricular Fibrillation

2020
Cardioversion of Post-Ablation Atrial Tachyarrhythmia with Ibutilide and Amiodarone: A Registry-Based Cohort Study.
    International journal of environmental research and public health, 2022, 05-28, Volume: 19, Issue:11

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cohort Studies; Electric Countershock; Humans; Registries; Sulfonamides; Tachycardia; Treatment Outcome

2022